Related Experiment Video

Updated: May 10, 2026

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma

David A Reardon1, Kai W Wucherpfennig, Gordon Freeman

  • 1Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA. david_reardon@dfci.harvard.edu

Expert Review of Vaccines
|June 12, 2013
PubMed

Insights

Glioblastoma (GBM) immunotherapy shows promise but requires optimization. Current active immunotherapy studies for GBM confirm safety but reveal modest efficacy, highlighting the need for improved vaccination strategies and addressing tumor-induced immunosuppression.

Area of Science:

  • Neuro-oncology
  • Immunology
  • Cancer research

Background:

  • Glioblastoma (GBM) is the most common primary central nervous system (CNS) malignancy with a poor prognosis.
  • Recent successes in immunotherapy for other cancers warrant investigation into immunotherapeutic approaches for GBM.
  • The CNS is now recognized as immunocompetent, with active immune interactions.

Purpose of the Study:

  • To evaluate the potential of active immunotherapy for glioblastoma.
  • To review current immunotherapy strategies and their outcomes in GBM treatment.
  • To identify challenges and future directions for GBM immunotherapy.

Main Methods:

  • Review of active immunotherapy studies for GBM, including tumor lysate and synthetic antigen vaccination.
  • Analysis of safety, efficacy, and immunogenicity data from preclinical and clinical studies.
  • Consideration of factors contributing to GBM immunosuppression.

Main Results:

  • Active immunotherapy studies for GBM demonstrate consistent safety with no observed autoimmune reactivity.
  • Modest efficacy and variable immunogenicity have been reported in current GBM immunotherapy trials.
  • Systemic and local immunosuppression within the GBM tumor microenvironment presents significant challenges.

Conclusions:

  • Optimizing vaccination variables is crucial for enhancing GBM immunotherapy efficacy.
  • Addressing the immunosuppressive nature of GBM is essential for successful treatment.
  • Future research should explore combinatorial immunotherapy strategies for glioblastoma.

More Related Videos

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations04:46

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Published on: February 24, 2023

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...